Role of MRI in Diagnosis of Postpartum Neurological Disorders

March 1, 2025 updated by: Petet Gadallah Nazir, Sohag University
Role of MRI in diagnosis of postpartum neurological disorders

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

50

Description

Inclusion Criteria:

  1. Female gender.
  2. Age more than 18 years old.
  3. Patients presented with neurological complaint in 3 months following childbirth.

Exclusion Criteria:

  1. Male gender.
  2. Female younger than 18 years old
  3. Contraindication to perform MRI examination. These include:- Cardiac pacemaker.- Metallic aneurysm clips.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of MRI Abnormalities in Postpartum Neurological Cases
Time Frame: 16 months
This outcome measures the number of postpartum patients presenting with different types of MRI abnormalities, including PRES (Posterior Reversible Encephalopathy Syndrome), cerebral venous thrombosis, and other neurological conditions. The study aims to categorize and quantify these findings to better understand their prevalence and role in postpartum neurological disorders.
16 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2024

Primary Completion (Estimated)

October 2, 2025

Study Completion (Estimated)

October 2, 2025

Study Registration Dates

First Submitted

February 18, 2025

First Submitted That Met QC Criteria

March 1, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 1, 2025

Last Verified

September 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--25-1-01MS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe